4-Chloro-2-methylbenzonitrile

We are 4-Chloro-2-methylbenzonitrile CAS:50712-68-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Chloro-2-methylbenzonitrile
CAS.NO:50712-68-0
Synonyms:4-Chloro-2-methylbenzonitrile
5-Chloro-2-cyanotoluene
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 239.8±20.0 °C at 760 mmHg
Melting Point 57-61 °C(lit.)
Molecular Formula C8H6ClN
Molecular Weight 151.593
Flash Point 97.1±16.8 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.553
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Chloro-2-methylbenzonitrile


Related News: The best you can do is take medicines and treatments for specific symptoms.2-Aminophenol Hemisulfate Salt CAS:67845-79-8 After nearly ten years of growth, China’s fine chemical industry has made considerable progress. At present, China’s overall refinement rate (that is, the output value rate of fine chemicals = total value of fine chemical products / total value of chemical products * 100%) has reached about 40%. Some fine chemical products have certain international competitiveness and become important processing and exporting places of fine chemical raw materials and intermediates in the world.3,6-dichloro-2-hydroxybenzoic acid CAS:3401-80-7 According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).Bis (metiltio) metano CAS:1618-26-4 Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.

Related Products
Product Name
1-(3-Amino-2-hydroxyphenyl)ethanone View Details
Triphenylmethyl Chloride View Details
Isobutyl Isothiocyanate View Details
3-Nitro-4-hydroxyquinoline manufacturer 1,2-DIIODOETHANE manufacturer 1-isothiocyanato-4-(trifluoromethoxy)benzene manufacturer 2-Bromopropionyl bromide manufacturer ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate manufacturer